Skip to main content

Macroscopic Serosal Classification Predicts Peritoneal Recurrence for Patients with Gastric Cancer Underwent Potentially Curative Surgery

Annals of Surgical Oncology volume 18, pages 1068–1080 (2011)Cite this article

Abstract

Background

Previous studies revealed serosal invasion as one of the most important predictors of peritoneal micrometastasis. However, even for cancers with serosal invasion, the macroscopic serosal appearance is highly heterogeneous. The aim of the present study was to propose a macroscopic serosal classification (MSC) and to investigate the validity of this classification as a predictor of peritoneal recurrence.

Materials and Methods

Clinicopathologic features including MSC of 1528 patients with pT3/pT4a stage gastric cancers who underwent potentially radical surgery were retrospectively reviewed. MSC was classified as reactive type, nodular type, tendonoid type, and color-diffused type according to the macroscopic serosal appearance.

Results

There were significant differences in tumor size, location, Bormann type, Lauren grade, lymphatic and/or blood vessels invasion (LBVI), width of serosa changes, depth of invasion, number of nodes metastasis, lymph node metastasis ratio, pN stage, and peritoneal cytology between patients with different types of serosa. Multivariate analysis revealed MSC, as well as depth of invasion, Lauren grade, and pN stage, significantly predicted the presence of peritoneal-free cancer cells. Both MSC and peritoneal cytology significantly correlated with patient survival. However, only MSC significantly predicted peritoneal recurrence on multivariate analysis, but peritoneal cytology did not, indicating MSC was more sensitive than cytologic examination. Further investigation suggested MSC and pN stage were also independent predictors of peritoneal recurrence for patients with negative peritoneal cytology.

Conclusions

The MSC sensitively predicts the presence of peritoneal micrometastasis for pT3/pT4a-stage gastric cancer patients who underwent potentially radical surgery. Consequently, it might be considered a good indicator to guide perioperative adjuvant therapy for patients with high risk of peritoneal recurrence.

This is a preview of subscription content, access via your institution.

Access options

Buy single article

Instant access to the full article PDF.

43,34 €

Price includes VAT (Finland)
Tax calculation will be finalised during checkout.

Fig. 1
Fig. 2

References

  1. Jemal A, Siegel R, Ward E, Hao Y, Xu J, Murray T, et al. Cancer statistics, 2008. CA Cancer J Clin. 2008;58:71–96.

    PubMed  Article  Google Scholar 

  2. Goggins WB, Wong GK. Poor survival for US Pacific Islander cancer patients: evidence from the Surveillance, Epidemiology, and End Results database: 1991 to 2004. J Clin Oncol. 2007;25:5738–41.

    PubMed  Article  Google Scholar 

  3. D’Angelica M, Gonen M, Brennan MF, Turnbull AD, Bains M, Karpeh MS. Patterns of initial recurrence in completely resected gastric adenocarcinoma. Ann Surg. 2004;240:808–16.

    PubMed  Article  Google Scholar 

  4. Roviello F, Marrelli D, de Manzoni G, Morgagni P, Di Leo A, Saragoni L, et al. Prospective study of peritoneal recurrence after curative surgery for gastric cancer. Br J Surg. 2003;90:1113–9.

    PubMed  Article  CAS  Google Scholar 

  5. Benevolo M, Mottolese M, Cosimelli M, Tedesco M, Giannarelli D, Vasselli S, et al. Diagnostic and prognostic value of peritoneal immunocytology in gastric cancer. J Clin Oncol. 1998;16:3406–11.

    PubMed  CAS  Google Scholar 

  6. Bonenkamp JJ, Songun I, Hermans J, van de Velde CJ. Prognostic value of positive cytology findings from abdominal washings in patients with gastric cancer. Br J Surg. 1996;83:672–4.

    PubMed  Article  CAS  Google Scholar 

  7. Abe S, Yoshimura H, Tabata H, Tachibana M, Monden N, Nakamura T, et al. Curative resection of gastric cancer: limitation of peritoneal lavage cytology in predicting the outcome. J Surg Oncol. 1995;59:226–9.

    PubMed  Article  CAS  Google Scholar 

  8. Kodera Y, Nakanishi H, Ito S, Yamamura Y, Kanemitsu Y, Shimizu Y, et al. Quantitative detection of disseminated free cancer cells in peritoneal washes with real-time reverse transcriptase-polymerase chain reaction: a sensitive predictor of outcome for patients with gastric carcinoma. Ann Surg. 2002;235:499–506.

    PubMed  Article  Google Scholar 

  9. Nakanishi H, Kodera Y, Yamamura Y, Ito S, Kato T, Ezaki T, et al. Rapid quantitative detection of carcinoembryonic antigen-expressing free tumor cells in the peritoneal cavity of gastric cancer patients with real-time RT-PCR on the lightcycler. Int J Cancer. 2000;89:411–7.

    PubMed  Article  CAS  Google Scholar 

  10. Ito S, Nakanishi H, Kodera Y, Mochizuki Y, Tatematsu M, Yamamura Y. Prospective validation of quantitative CEA mRNA detection in peritoneal washes in gastric carcinoma patients. Br J Cancer. 2005;93:986–92.

    PubMed  Article  CAS  Google Scholar 

  11. Baba H, Korenaga D, Okamura T, Saito A, Sugimachi K. Prognostic factors in gastric cancer with serosal invasion: univariate and multivariate analyses. Arch Surg. 1989;124:1061–4.

    PubMed  CAS  Google Scholar 

  12. Sobin L, Gospodarowicz M, Wittekind C, eds. TNM Classification of Malignant Tumours. 7th ed. International Union Against Cancer (UICC). New York: Wiley, 2009.

    Google Scholar 

  13. Ichiyoshi Y, Maehara Y, Tomisaki S, Oiwa H, Sakaguchi Y, Ohno S, et al. Macroscopic intraoperative diagnosis of serosal invasion and clinical outcome of gastric cancer: risk of underestimation. J Surg Oncol. 1995;59:255–60.

    PubMed  Article  CAS  Google Scholar 

  14. Kodera Y, Yamamura Y, Shimizu Y, Torii A, Hirai T, Yasui K, et al. Peritoneal washing cytology: prognostic value of positive findings in patients with gastric carcinoma undergoing a potentially curative resection. J Surg Oncol. 1999;72:60–4 (discussion 64–5).

    PubMed  Article  CAS  Google Scholar 

  15. Japanese Gastric Cancer A. Japanese classification of gastric carcinoma—2nd English edition. Gastric Cancer. 1998;1:10–24.

    Article  Google Scholar 

  16. Homma Y, Ushida S, Yamada M, Kobayashi H, Suzuki K. Positive peritoneal washing cytology in multiple cavities can predict poor prognosis of advanced gastric cancer patients. Ann Surg Oncol. 2010;17:455–60.

    PubMed  Article  Google Scholar 

  17. Marrelli D, Roviello F, de Manzoni G, Morgagni P, Di Leo A, Saragoni L, et al. Different patterns of recurrence in gastric cancer depending on Lauren’s histological type: longitudinal study. World J Surg. 2002;26:1160–5.

    PubMed  Article  Google Scholar 

  18. Soga K, Ichikawa D, Yasukawa S, Kubota T, Kikuchi S, Fujiwara H, et al. Prognostic impact of the width of subserosal invasion in gastric cancer invading the subserosal layer. Surgery. 2010;147:197–203.

    PubMed  Article  Google Scholar 

  19. Bando E, Kawamura T, Kinoshita K, Takahashi S, Maeda A, Osada S et al. Magnitude of serosal changes predicts peritoneal recurrence of gastric cancer. J Am Coll Surg. 2003;197:212–22.

    PubMed  Article  Google Scholar 

  20. Abe S, Shiraishi M, Nagaoka S, Yoshimura H, Dhar DK, Nakamura T. Serosal invasion as the single prognostic indicator in stage III A (T3N1M0) gastric cancer. Surgery. 1991;6:582–8.

    Google Scholar 

  21. Baba H, Korenaga D, Haraguchi M, Okamura T, Saito A, Watanabe A, et al. Width of serosal invasion and prognosis in advanced human gastric cancer with special reference to the mode of tumor invasion. Cancer. 1989;15:2482–6.

    Article  Google Scholar 

  22. Fujimoto S, Takahashi M, Mutou T, Kobayashi K, Toyosawa T. Successful intraperitoneal hyperthermic chemoperfusion for the prevention of postoperative peritoneal recurrence in patients with advanced gastric carcinoma. Cancer. 1999;85:529–34.

    PubMed  Article  CAS  Google Scholar 

  23. Rosen HR, Jatzko G, Repse S, Potrc S, Neudorfer H, Sandbichler P, et al. Adjuvant intraperitoneal chemotherapy with carbon-adsorbed mitomycin in patients with gastric cancer: results of a randomised multi-center trial of the Austrian Working Group for Surgical Oncology. J Clin Oncol. 1998;16:2733–8.

    PubMed  CAS  Google Scholar 

  24. Verwaal VJ, van Ruth S, de Bree E, van Sloothen GW, van Tinteren H, Boot H, et al. Randomized trial of cytoreduction and hyperthermic intraperitoneal chemotherapy versus systemic chemotherapy and palliative surgery in patients with peritoneal carcinomatosis of colorectal cancer. J Clin Oncol. 2003;21:3737–43.

    PubMed  Article  Google Scholar 

  25. Chua TC, Morris DL, Esquivel J. Impact of the peritoneal surface disease severity score on survival in patients with colorectal cancer peritoneal carcinomatosis undergoing complete cytoreduction and hyperthermic intraperitoneal chemotherapy. Ann Surg Oncol. 2010;17:1330–6.

    PubMed  Article  Google Scholar 

  26. Yan TD, Black D, Sugarbaker PH, Zhu J, Yonemura Y, Petrou G, et al. A systematic review and meta-analysis of the randomized controlled trials on adjuvant intraperitoneal chemotherapy for resectable gastric cancer. Ann Surg Oncol. 2007;14:2702–13.

    PubMed  Article  Google Scholar 

  27. Yan TD, Deraco M, Baratti D, Kusamura S, Elias D, Glehen O, et al. Cytoreductive surgery and hyperthermic intraperitoneal chemotherapy for malignant peritoneal mesothelioma: multi-institutional experience. J Clin Oncol. 2009;27:6237–42.

    PubMed  Article  Google Scholar 

  28. Bakkevold KE, Kambestad B. Morbidity and mortality after radical and palliative pancreatic cancer surgery. Risk factors influencing the short-term results. Ann Surg. 1993;217:356–68.

    PubMed  Article  CAS  Google Scholar 

  29. Kusamura S, Younan R, Baratti D, Costanzo P, Favaro M, Gavazzi C, et al. Cytoreductive surgery followed by intraperitoneal hyperthermic perfusion: analysis of morbidity and mortality in 209 peritoneal surface malignancies treated with closed abdomen technique. Cancer. 2006;106:1144–53.

    PubMed  Article  Google Scholar 

  30. Elias D, Goere D, Blot F, Billard V, Pocard M, Kohneh-Shahri N, et al. Optimization of hyperthermic intraperitoneal chemotherapy with oxaliplatin plus irinotecan at 43 degrees C after compete cytoreductive surgery: mortality and morbidity in 106 consecutive patients. Ann Surg Oncol. 2007;14:1818–24.

    PubMed  Article  Google Scholar 

  31. Yan TD, Black D, Savady R, Sugarbaker PH. Systematic review on the efficacy of cytoreductive surgery combined with perioperative intraperitoneal chemotherapy for peritoneal carcinomatosis from colorectal carcinoma. J Clin Oncol. 2006;24:4011–9.

    PubMed  Article  Google Scholar 

  32. Chua TC, Yan TD, Saxena A, Morris DL. Should the treatment of peritoneal carcinomatosis by cytoreductive surgery and hyperthermic intraperitoneal chemotherapy still be regarded as a highly morbid procedure?: a systematic review of morbidity and mortality. Ann Surg. 2009;249:900–7.

    PubMed  Article  Google Scholar 

Download references

Acknowledgment

Supported by grants from the National Natural Science Foundation of China (no. 30901419).

Author information

Affiliations

  1. Department of Surgical Oncology, First Affiliated Hospital of China Medical University, Shenyang, Liaoning, China

    Zhe Sun MD, Ying-ying Xu MD, Zhen-ning Wang MD, Zhi Zhu MD, Hao Zhang MD, Bao-jun Huang MD, Yan Xu MD, Jun-qing Chen MD & Hui-mian Xu MD

Authors
  1. Zhe Sun MD
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Ying-ying Xu MD
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. Zhen-ning Wang MD
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. Zhi Zhu MD
    View author publications

    You can also search for this author in PubMed Google Scholar

  5. Hao Zhang MD
    View author publications

    You can also search for this author in PubMed Google Scholar

  6. Bao-jun Huang MD
    View author publications

    You can also search for this author in PubMed Google Scholar

  7. Yan Xu MD
    View author publications

    You can also search for this author in PubMed Google Scholar

  8. Jun-qing Chen MD
    View author publications

    You can also search for this author in PubMed Google Scholar

  9. Hui-mian Xu MD
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding authors

Correspondence to Zhen-ning Wang MD or Hui-mian Xu MD.

Rights and permissions

Reprints and Permissions

About this article

Cite this article

Sun, Z., Xu, Yy., Wang, Zn. et al. Macroscopic Serosal Classification Predicts Peritoneal Recurrence for Patients with Gastric Cancer Underwent Potentially Curative Surgery. Ann Surg Oncol 18, 1068–1080 (2011). https://doi.org/10.1245/s10434-010-1449-6

Download citation

  • Received:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1245/s10434-010-1449-6

Keywords

  • Gastric Cancer
  • Mesothelial Cell
  • Regional Lymph Node Metastasis
  • Peritoneal Recurrence
  • Serosal Invasion